文献速递腹部CT

基于CT的影像组学列线图预测胃癌神经周围侵犯及生存的多机构开发与外部验证研究

Development and External Validation of a CT-Based Radiomics Nomogram to Predict Perineural Invasion and Survival in Gastric Cancer: A Multi-institutional Study.
PubMed 文献 · Acad Radiol · 2024-08-10

回顾性分析两家机构408例胃癌患者,机构I的288例按7:3分为训练集203例和测试集85例,机构II的120例作为外部验证集,从CT图像提取并筛选影像组学特征构建预测神经周围侵犯的模型。影像组学列线图在训练集、测试集和外部验证集的AUC分别为0.872、0.862和0.837,高于临床模型(P<0.05),高危及低危组无复发生存期差异有统计学意义(HR 4.329,95%CI 3.159-5.934,P<0.001)。

要点

  • CT影像组学列线图可无创预测胃癌神经周围侵犯,外部验证AUC为0.837。
  • 列线图预测效能优于临床模型(P<0.05)。
  • 列线图划分的高危组无复发生存期显著更短(HR 4.329,P<0.001)。

核心结论

  • 基于CT的影像组学列线图是预测胃癌神经周围侵犯的有前景工具,并具有显著预后意义。

研究设计与样本

  • 回顾性分析两家机构408例胃癌患者,机构I的288例按7:3分为训练集203例和测试集85例,机构II的120例为外部验证集,从CT图像提取并筛选影像组学特征,构建影像组学、临床及联合模型预测神经周围侵犯。

诊断标准与关键数值

  • 影像组学模型预测神经周围侵犯的AUC:训练集0.843(95%CI 0.788-0.897)、测试集0.831(95%CI 0.741-0.920)、外部验证集0.802(95%CI 0.722-0.882)。
  • 列线图预测神经周围侵犯的AUC:训练集0.872(95%CI 0.823-0.921)、测试集0.862(95%CI 0.780-0.944)、外部验证集0.837(95%CI 0.767-0.908)。
  • 最终分析纳入15个影像组学特征和3个临床因素。
  • 列线图预测效能优于临床模型(P<0.05)。
  • 列线图高危组无复发生存期显著短于低危组(HR 4.329,95%CI 3.159-5.934,P<0.001)。

临床应用与阅片要点

  • 列线图可作为确定神经周围侵犯状态的无创生物标志物。
  • 列线图预测效能优于临床模型(P<0.05),可用于术前评估神经周围侵犯风险。
  • 列线图划分的高危组无复发生存期显著更短(P<0.05),提示其具有预后分层价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop and validate a radiomics nomogram utilizing CT data for predicting perineural invasion (PNI) and survival in gastric cancer (GC) patients.

MATERIALS AND METHODS: A retrospective analysis of 408 GC patients from two institutions: 288 patients from Institution I were divided 7:3 into a training set (n = 203) and a testing set (n = 85); 120 patients from Institution II served as an external validation set. Radiomics features were extracted and screened from CT images. Independent radiomics, clinical, and combined models were constructed to predict PNI. Model discrimination, calibration, clinical utility, and prognostic significance were evaluated using area under the curve (AUC), calibration curves, decision curves analysis, and Kaplan-Meier curves, respectively.

RESULTS: 15 radiomics features and three clinical factors were included in the final analysis. The AUCs of the radiomics model in the training, testing, and external validation sets were 0.843 (95% CI: 0.788-0.897), 0.831 (95% CI: 0.741-0.920), and 0.802 (95% CI: 0.722-0.882), respectively. A nomogram was developed by integrating significant clinical factors with radiomics features. The AUCs of the nomogram in the training, testing, and external validation sets were 0.872 (95% CI: 0.823-0.921), 0.862 (95% CI: 0.780-0.944), and 0.837 (95% CI: 0.767-0.908), respectively. Survival analysis revealed that the nomogram could effectively stratify patients for recurrence-free survival (Hazard Ratio: 4.329; 95% CI: 3.159-5.934; P < 0.001).

CONCLUSION: The radiomics-derived nomogram presented a promising tool for predicting PNI in GC and held significant prognostic implications.

IMPORTANT FINDINGS: The nomogram functioned as a non-invasive biomarker for determining the PNI status. The predictive performance of the nomogram surpassed that of the clinical model (P < 0.05). Furthermore, patients in the high-risk group stratified by the nomogram had a significantly shorter RFS (P < 0.05).

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Xu G, Feng F, Chen W, et al. Development and External Validation of a CT-Based Radiomics Nomogram to Predict Perineural Invasion and Survival in Gastric Cancer: A Multi-institutional Study. Acad Radiol. 2024. PMID: 39127522. doi:10.1016/j.acra.2024.07.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。